GSE202434 GSE202438 talazoparib 15 v 14 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE202434_GSE202438_talazoparib_15_v_14_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE202434_GSE202438_talazoparib_15_v_14_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE202434_GSE202438_talazoparib_15_v_14_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE202434_GSE202438_talazoparib_15_v_14_human_up.

Results found

Linked to

 

Label

Description

 

Gene

Pvt1 oncogene

Gene

PAX8 antisense RNA 1

Gene

VPS9D1 antisense RNA 1

Gene

NmrA like redox sensor 2, pseudogene

Gene

long intergenic non-protein coding RNA 973

Gene

MT-ND2 pseudogene 28

Gene

long intergenic non-protein coding RNA 1806

Gene

MT-ND4 pseudogene 12

Gene

APCDD1L divergent transcript

Gene

arylacetamide deacetylase pseudogene 1


  • Gene

    PAX8 antisense RNA 1


  • Gene

    VPS9D1 antisense RNA 1


  • Gene

    NmrA like redox sensor 2, pseudogene


  • Gene

    long intergenic non-protein coding RNA 973


  • Gene

    MT-ND2 pseudogene 28


  • Gene

    long intergenic non-protein coding RNA 1806


  • Gene

    MT-ND4 pseudogene 12


  • Gene

    APCDD1L divergent transcript


  • Gene

    arylacetamide deacetylase pseudogene 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.